-
Featured
Paradigm Change: Patient and Provider Expectations Around Same-day Discharge
Newly modified enhanced recovery after surgery (ERAS) protocol guides same-day discharge of vaginal hysterectomy patients while maintaining quality of patient care.
-
Featured
Evaluating Post-Menopausal Women's Vulvovaginal Symptoms, Mood and Sex Life
These pioneering studies from Massachusetts General Hospital evaluate the efficacy of two common, low-risk treatments for postmenopausal symptoms against a placebo and assess how much postmenopausal women were bothered by vulvovaginal discomfort symptoms, along with their impact on mood and quality of life.
-
Featured
Vaginal Estradiol, Moisturizer No Better Than Placebo for Postmenopausal Vulvovaginal Symptoms
Neither a prescription vaginal estradiol tablet nor an over-the-counter vaginal moisturizer provides additional benefit over dual placebo in reducing postmenopausal vulvovaginal symptoms, according to the first randomized comparison.
-
Telemedicine Well Accepted in Urogynecology Clinic Early in the COVID-19 Pandemic
Physicians in the Female Pelvic Medicine & Reconstructive Surgery Program at Massachusetts General Hospital found that 81% of patients reported no trouble with telemedicine technology early in the COVID-19 pandemic. During this time period, 89% of patients were willing to continue telemedicine regardless of age or difficulty with the technology.
-
Review: Lesions of the Ovary and Fallopian Tube
Rachel C. Sisodia, MD, and Marcela G. del Carmen, MD, MPH, emphasize that all patients with a high-risk lesion of the ovary or fallopian tube should be referred to a gynecologic oncologist, as multiple studies have shown comprehensive surgical staging and tumor debulking is associated with improved overall survival.
-
Innovative Research on Modifying Vaginal Microbiome to Treat Bacterial Vaginosis
The MOTIF clinical trial, led by Caroline Mitchell, MD, MPH, in the Department of Obstetrics and Gynecology at Massachusetts General Hospital, evaluates vaginal fluid transplantation as a preventive therapy for recurrent bacterial vaginosis.
Gynecology Contributors
-
Caroline M. Mitchell, MD
Director, Vulvovaginal Disorders Program, Investigator, Vincent Center for Reproductive Biology , Assistant Professor, Obstetrics, Gynecology & Reproductive Biology
Recent Article
Innovative Research on Modifying Vaginal Microbiome to Treat Bacterial Vaginosis
-
May M. Wakamatsu, MD
Director, Female Pelvic Medicine & Reconstructive Surgery, Vice Chair, Gynecology
Recent Article
IMPACT: A Standardized Tool for Assessment of Pelvic Floor Disorders
-
Milena M. Weinstein, MD
Director of Research, Female Pelvic Medicine and Reconstructive Surgery Fellowship, Co-director, Center for Pelvic Floor Disorders
Recent Article
Vaginal Prolapse May Not Correlate With Radiographic Findings in Symptomatic ODS Patients
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.